Salvage living donor liver transplantation for posthepatectomy recurrence: a higher incidence of recurrence but promising strategy for long-term survival

References

• Dhir M, Melin AA, Douaiher J, et al. A review and update of treatment options and controversies in the management of hepatocellular carcinoma. Ann Surg. 2016;263:1112–1125.26813914
   PubMed Web of Science ®Google Scholar
• Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693–699. doi:10.1056/NEJM1996031433411048594428
   PubMed Web of Science ®Google Scholar
• Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology. 2001;33:1394–1403. doi:10.1053/jhep.2001.2456311391528
   PubMed Web of Science ®Google Scholar
• Bhangui P, Allard MA, Vibert E, et al. Salvage versus primary liver transplantation for early hepatocellular carcinoma: do both strategies yield similar outcomes? Ann Surg. 2016;264:155–163. doi:10.1097/SLA.000000000000144226649581
   PubMed Web of Science ®Google Scholar
• Fuks D, Dokmak S, Paradis V, Diouf M, Durand F, Belghiti J. Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis. Hepatology. 2012;55:132–140. doi:10.1002/hep.2468021932387
   PubMed Web of Science ®Google Scholar
• Majno PE, Sarasin FP, Mentha G, Hadengue A. Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome-oriented decision analysis. Hepatology. 2000;31:899–906. doi:10.1053/he.2000.576310733546
   PubMed Web of Science ®Google Scholar
• Lee CF, Cheng CH, Wang YC, et al. Adult living donor liver transplantation across ABO-incompatibility. Medicine (Baltimore). 2015;94:e1796. doi:10.1097/MD.000000000000087426496313
   PubMed Web of Science ®Google Scholar
• Chan KM, Yu MC, Chou HS, Wu T-J, Lee C-F, Lee W-C. Significance of tumor necrosis for outcome of patients with hepatocellular carcinoma receiving locoregional therapy prior to liver transplantation. Ann Surg Oncol. 2011;18:2638–2646. doi:10.1245/s10434-011-1779-z21584831
   PubMed Web of Science ®Google Scholar
• Wu TJ, Chan KM, Chou HS, et al. Liver transplantation in patients with hepatitis B virus-related hepatocellular carcinoma: the influence of viral characteristics on clinical outcome. Ann Surg Oncol. 2013;20:3582–3590. doi:10.1245/s10434-013-3023-523760589
   PubMed Web of Science ®Google Scholar
• Trotter JF. Liver transplantation around the world. Curr Opin Organ Transplant. 2017;22:123–127. doi:10.1097/MOT.000000000000039228151809
   PubMed Web of Science ®Google Scholar
• Chen CL, Kabiling CS, Concejero AM. Why does living donor liver transplantation flourish in Asia? Nat Rev Gastroenterol Hepatol. 2013;10:746–751. doi:10.1038/nrgastro.2013.19424100300
   PubMed Web of Science ®Google Scholar
• Shukla A, Vadeyar H, Rela M, Shah S. Liver transplantation: east versus west. J Clin Exp Hepatol. 2013;3:243–253. doi:10.1016/j.jceh.2013.08.00425755506
   PubMedGoogle Scholar
• Goldaracena N, Gorgen A, Doyle A, et al. Live donor liver transplantation for patients with hepatocellular carcinoma offers increased survival vs. deceased donation. J Hepatol. 2019;70:666–673. doi:10.1016/j.jhep.2018.12.02930630009
   PubMedGoogle Scholar
• Bhangui P, Vibert E, Majno P, et al. Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: living versus deceased donor transplantation. Hepatology. 2011;53:1570–1579. doi:10.1002/hep.2423121520172
   PubMed Web of Science ®Google Scholar
• Wong TCL, Ng KKC, Fung JYY, et al. Long-term survival outcome between living donor and deceased donor liver transplant for hepatocellular carcinoma: intention-to-treat and propensity score matching analyses. Ann Surg Oncol. 2019;26:1454–1462.
   Web of Science ®Google Scholar
• Lee S, Ahn C, Ha T, et al. Liver transplantation for hepatocellular carcinoma: Korean experience. J Hepatobiliary Pancreat Sci. 2010;17:539–547. doi:10.1007/s00534-009-0167-619727542
   PubMed Web of Science ®Google Scholar
• Sugawara Y, Tamura S, Makuuchi M. Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series. Dig Dis. 2007;25:310–312. doi:10.1159/00010691017960065
   PubMed Web of Science ®Google Scholar
• Takada Y, Uemoto S. Liver transplantation for hepatocellular carcinoma: the Kyoto experience. J Hepatobiliary Pancreat Sci. 2010;17:527–532. doi:10.1007/s00534-009-0162-y19707711
   PubMed Web of Science ®Google Scholar
• Zheng SS, Xu X, Wu J, et al. Liver transplantation for hepatocellular carcinoma: Hangzhou experiences. Transplantation. 2008;85:1726–1732. doi:10.1097/TP.0b013e31816b67e418580463
   PubMed Web of Science ®Google Scholar
• Rhu J, Kim JM, Choi GS, et al. The impact of extra-anatomical hepatic artery reconstruction during living donor liver transplantation on biliary complications and graft and patient survival. Transplantation.2019; 1. doi:10.1097/TP.000000000000260130399124
   PubMedGoogle Scholar
• Choi HJ, Kim DG, Na GH, et al. The clinical outcomes of patients with portal vein tumor thrombi after living donor liver transplantation. Liver Transpl. 2017;23:1023–1031. doi:10.1002/lt.2478228480517
   PubMed Web of Science ®Google Scholar
• Wu L, Hu A, Tam N, et al. Salvage liver transplantation for patients with recurrent hepatocellular carcinoma after curative resection. PLoS One. 2012;7:e41820. doi:10.1371/journal.pone.004182022848619
   PubMed Web of Science ®Google Scholar
• Cucchetti A, Vitale A, Del Gaudio M, et al. Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma. Am J Transplant. 2010;10:619–627. doi:10.1111/j.1600-6143.2009.02984.x20121741
   PubMed Web of Science ®Google Scholar
• Eguchi S, Hidaka M, Tomonaga T, et al. Actual therapeutic efficacy of pre-transplant treatment on hepatocellular carcinoma and its impact on survival after salvage living donor liver transplantation. J Gastroenterol. 2009;44:624–629. doi:10.1007/s00535-009-0043-919381752
   PubMed Web of Science ®Google Scholar
• de Haas RJ, Lim C, Bhangui P, et al. Curative salvage liver transplantation in patients with cirrhosis and hepatocellular carcinoma: an intention-to-treat analysis. Hepatology. 2018;67:204–215. doi:10.1002/hep.2946828806477
   PubMed Web of Science ®Google Scholar
• Lim C, Shinkawa H, Hasegawa K, et al. Salvage liver transplantation or repeat hepatectomy for recurrent hepatocellular carcinoma: an intent-to-treat analysis. Liver Transpl. 2017;23:1553–1563. doi:10.1002/lt.2495228945955
   PubMed Web of Science ®Google Scholar
• Guerrini GP, Gerunda GE, Montalti R, et al. Results of salvage liver transplantation. Liver Int. 2014;34:e96–e104. doi:10.1111/liv.1249724517642
   PubMed Web of Science ®Google Scholar
• Del Gaudio M, Ercolani G, Ravaioli M, et al. Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience. Am J Transplant. 2008;8:1177–1185. doi:10.1111/j.1600-6143.2008.02229.x18444925
   PubMed Web of Science ®Google Scholar
• Sarasin FP, Majno PE, Llovet JM, Bruix J, Mentha G, Hadengue A. Living donor liver transplantation for early hepatocellular carcinoma: a life-expectancy and cost-effectiveness perspective. Hepatology. 2001;33:1073–1079. doi:10.1053/jhep.2001.2331111343234
   PubMed Web of Science ®Google Scholar